JO
ABVX

John Overdeck’s Abivax ABVX Stock Holding History

John Overdeck’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-19,736
Closed -$144K – 3163
2024
Q4 		$144K Buy
+19,736
New +$182K ﹤0.01% 2921

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

John Overdeck's ABVX Position: Q1 2025 in Review

John Overdeck sold out of Abivax (ABVX) in Q1 2025, closing a stake of 19,736 shares — an estimated $144K sold.

John Overdeck first reported a position in ABVX in Q4 2024 and held it in 1 quarter. The position peaked at $144K in Q4 2024. 46 funds tracked by Wall St. Rank hold ABVX as of Q1 2025.

  • John Overdeck reported no remaining Abivax position as of Q1 2025 after selling out during the quarter.
  • John Overdeck sold 19,736 Abivax shares in Q1 2025, an estimated $144K.
  • John Overdeck first reported a position in Abivax in Q4 2024 and held it in 1 quarter.
  • John Overdeck's Abivax position peaked at $144K in Q4 2024.
  • 46 funds tracked by Wall St. Rank held Abivax as of Q1 2025.

Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.